Obalon Therapeutics, Inc. vs. Polyzen, Inc.
Explore the PTAB proceeding IPR2017-00812 filed by Obalon Therapeutics, Inc. on 2017-01-30. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-00812
Filing Date
2017-01-30
Accorded Filing Date
2017-01-30
Institution Decision Date
β
Last Modified Date
2017-10-23
Proceeding Type
IPR
Termination Date
2017-08-21
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Obalon Therapeutics, Inc.
Represented By
Peng ChenPatent Owner / Respondent
Polyzen, Inc.
Represented By
Steven HultquistPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1700 - Chemical & Materials Engineering
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28021 | Steven Hultquist | +1 919-419-9350 |
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 7,682,306 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,883,491 B2 | US Continuation / Sibling | View Official Patent → |
Obalon Therapeutics, Inc. v. POLYZEN, INC.